Anxiety-related Fixation Instability During LASIK

CompletedOBSERVATIONAL
Enrollment

2,435

Participants

Timeline

Start Date

August 15, 2018

Primary Completion Date

July 15, 2023

Study Completion Date

July 15, 2023

Conditions
Refractive Errors
Interventions
PROCEDURE

Laser in situ keratomileusis (LASIK)

"Patients were planned to undergo laser in situ keratomileusis. Local anesthesia was achieved by preservative-free oxybuprocaine hydrochloride 0.4% drops (a commonly used topical anesthetic due to its effectiveness in alleviating pain and ocular surface discomfort during the procedure). During surgery, the lights of the operating room were dimmed as much as possible and the surgeons spoke to the patients in a calm voice and explained what was happening. They also reassured the patients that the surgery was going as planned and would be over soon.~For patients undergoing (Microkeratome) MK-LASIK, a Moria 2 Microkeratome (Moria SA, Antony, France) was used to create the flap. For patients undergoing Femtosecond LASIK (FS-LASIK), the Allegretto Wave Light FS-200 femtosecond Laser (Alcon labs, Fort Worth, TX, USA) was used for flap creation.~Laser ablation was performed using WaveLight EX500 Excimer Laser (Alcon labs, Fort Worth, TX, USA) with a planned post-operative emmetropia."

Trial Locations (1)

71516

Tiba Eye Center, Asyut

All Listed Sponsors
lead

Assiut University

OTHER

NCT06148428 - Anxiety-related Fixation Instability During LASIK | Biotech Hunter | Biotech Hunter